biased signaling is evolutionarily conserved, and why he chose a book over a review 48:09 Dinner with Martin Rodbell - drawing the FSH data on a napkin and hearing "I'm not surprised" 53:07 Advice for scientists "I'm not surprised." - Martin Rodbell, upon being shown Arey's FSH signaling data drawn on a dinner napkin , citing a 1972 paper in which Rodbell had proposed a similar mechanism.

Instructors at the course included Marc Chabre , Harden McConnell , Richard Henderson , Martin Rodbell , Jean-Pierre Changeux , and Martin Karplus .

<< Back to podcast list Strategic Partner(s) Martin Audet About Dr. Martin Audet Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke Martin Audet on the web LinkedIn Twitter Sherbrooke University Google Scholar Dr.

Jean Martin Beaulieu About Dr. Jean Martin Beaulieu Dr. Jean Martin Beaulieu on the web University of Toronto Google Scholar LinkedIn ResearchGate Dr.

Explore Martin Marro’s impact on GPCR drug discovery, assay innovation, and translational pharmacology About Martin Martin Marro is Head of Cell Pharmacology and Executive Director of the Obesity Research Martin Marro "It was inevitable to ask myself whether I had made the right decision. Martin Marro "Most experiments won't work. Most drugs won't make it. Martin Marro Guest Link - LinkedIn: https://www.linkedin.com/in/martinmarro/ Unlock the Full Dr.

Schihada Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin

During my PhD studies in Martin Lohse lab at the Max Delbrueck Center in Berlin, I consolidated my knowledge

Martine Smit . During his Ph.D., Timo, together with Dr.

Jean Martin Beaulieu (2003) Dr. Laura Bohn (1999) Dr. Kathleen Caron - Co-host- (1970) Dr.

Trained as a pharmacist, she earned her doctorate in Biomedicine in Martin Lohse's laboratory, where

in Molecular Pharmacology at Monash University, then trained in single-cell biology as an NHMRC CJ Martin

the most drugged protein family in medicine, but until recently their role in cancer was treated as marginal

chemically possible Thermostabilizing the beta-adrenergic receptor by 21 degrees Celsius was not a marginal

look at what it means to modulate opioid pharmacology downstream of the receptor — and why the safety margins